Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

587 Articles

Chris Lange | Dec 12, 2017 at 10:40 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Dec 6, 2017 at 10:05 AM EST

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately,…

Chris Lange | Nov 10, 2017 at 11:25 AM EST

Short Sellers Back Way Off Major Pharma

The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Oct 28, 2017 at 10:05 AM EDT

Top Biopharma Events Coming by the End of 2017

24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November…

Chris Lange | Oct 25, 2017 at 10:20 AM EDT

Short Sellers Hike Bets in Major Pharma

The October 13 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 22, 2017 at 10:45 AM EDT

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.

Jon C. Ogg | Oct 18, 2017 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Chevron, Chipotle, Exxon, Goldman Sachs, GoPro, IBM, Merck, Petrobras, UnitedHealth, Visa, Zynga and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Chevron, Chipotle Mexican Grill, Exxon Mobil, Goldman Sachs,…

Jon C. Ogg | Oct 16, 2017 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66, United Rentals and More

The top analyst upgrades, downgrades and other research calls from Monday include Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66…

Chris Lange | Oct 11, 2017 at 10:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Sep 27, 2017 at 9:00 AM EDT

Major Pharma Short Interest Piles On

The September 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 15, 2017 at 9:10 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle,…

Chris Lange | Sep 13, 2017 at 8:40 AM EDT

Major Pharma Short Interest Surges

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Sep 7, 2017 at 12:10 PM EDT

How Bristol-Myers Actually Won by Stopping a Clinical Study

Usually when a clinical study is stopped it spells disaster for the company performing the study, but in this case…

Chris Lange | Aug 25, 2017 at 9:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 10, 2017 at 8:40 AM EDT

Short Sellers Hike Bets in Major Pharma

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 17 18 19 20 21 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Short Sellers Can’t Make Up Their Minds on Major Pharma

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Short Sellers Back Way Off Major Pharma

Top Biopharma Events Coming by the End of 2017

Short Sellers Hike Bets in Major Pharma

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Top Analyst Upgrades and Downgrades: Chevron, Chipotle, Exxon, Goldman Sachs, GoPro, IBM, Merck, Petrobras, UnitedHealth, Visa, Zynga and More

Top Analyst Upgrades and Downgrades: Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66, United Rentals and More

Short Sellers Run for Cover From Major Pharma

Major Pharma Short Interest Piles On

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Major Pharma Short Interest Surges

How Bristol-Myers Actually Won by Stopping a Clinical Study

Short Sellers Run for Cover From Major Pharma

Short Sellers Hike Bets in Major Pharma

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

Prediction: Tesla Stock Will Hit $500 on This Date

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

Weirdly, the iPhone Might Be About to Become a Huge Drag on Apple’s Stock Price — or Maybe Not?

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Short Sellers Can’t Make Up Their Minds on Major Pharma

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Short Sellers Back Way Off Major Pharma

Top Biopharma Events Coming by the End of 2017

Short Sellers Hike Bets in Major Pharma

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Top Analyst Upgrades and Downgrades: Chevron, Chipotle, Exxon, Goldman Sachs, GoPro, IBM, Merck, Petrobras, UnitedHealth, Visa, Zynga and More

Top Analyst Upgrades and Downgrades: Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66, United Rentals and More

Short Sellers Run for Cover From Major Pharma

Major Pharma Short Interest Piles On

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Major Pharma Short Interest Surges

How Bristol-Myers Actually Won by Stopping a Clinical Study

Short Sellers Run for Cover From Major Pharma

Short Sellers Hike Bets in Major Pharma

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

Prediction: Tesla Stock Will Hit $500 on This Date

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

Featured Reads

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge